Article Details
Retrieved on: 2025-04-18 14:08:56
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Dr. Reddy’s Laboratories' growth strategies under Milan Kalawadia's leadership, highlighting expansions in biosimilars and self-care products. It addresses the pharmaceutical industry's shifts post-COVID, focusing on generic drugs' global market dynamics.
Article found on: www.pharmexec.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here